Cytoki Pharma
- Biotech or pharma, therapeutic R&D
Cytoki Pharma is a biotechnology company focused on metabolic disease and IBD (mucosal healing). Our lead program is a long-acting, optimised IL-22 analogue for once-weekly subcutaneous administration. Additionally, we have two pre-clinical IL-22 based projects focusing on directing the activity specifically to the GI tract to obtain full efficacy while maximizing tolerability. The two project are taking different formulation and molecule approaches and are aiming for once daily oral or once-weekly SC delivery, respectively.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}